A One Year Maintenance Study of Cobitolimod for the Treatment of Ulcerative Colitis
Latest Information Update: 15 Mar 2022
At a glance
- Drugs Cobitolimod (Primary)
- Indications Ulcerative colitis
- Focus Registrational; Therapeutic Use
- Sponsors InDex Pharmaceuticals
- 14 Mar 2022 According to an InDex Pharmaceuticals Holding AB media release, this study is expected to be completed in 2026.
- 27 Apr 2021 New trial record